News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Seattle Children’s aims to cure terminal brain cancer using immunotherapy with new BrainChild initiative

Al's Comment:

 This is a CAR-T cell trial. It is accepting children with any type of recurrent brain tumor that expresses the HER-2 receptor.

 


Posted on: 06/22/2018

Seattle Children’s aims to cure terminal brain cancer using immunotherapy with new BrainChild initiative

https://www.geekwire.com/2018/seattle-childrens-launches-brainchild-new-push-cure-children-terminal-brain-cancer-using-immunotherapy/

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740